Noninvasive diagnosis of hepatic fibrosis or cirrhosis.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Gastroenterology

• Publication date

  1997-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/GAST.1997.V113.PM9352863PMID 9352863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cirrhosis: Diagnosis by liver surface analysis with high-frequency ultrasound

  2005cited by this paper
• Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus

  1997cited by this paper
• Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy.

  1995cited by this paper
• [Interobserver concordance of echographic semiology in liver cirrhosis].

  1995cited by this paper
• Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

  1994cited by this paper
• Serum laminin in liver disease: an enzyme immunoassay study

  1994cited by this paper
• Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study

  1994cited by this paper
• McCormack's endoscopic signs for diagnosing portal hypertension: comparison with gastroesophageal varices.

  1994cited by this paper
• Alpha-2-macroglobulin and hepatic fibrosis

  1994cited by this paper
• Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon.

  1993cited by this paper
• Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis.

  1993cited by this paper
• Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis.

  1993cited by this paper
• Serum concentrations of laminin in cirrhosis of the liver.

  1993cited by this paper
• Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease

  1992cited by this paper
• Duplex‐Doppler assessment of cirrhosis in patients with chronic compensated liver disease

  1992cited by this paper
• Limitations of liver surface US in the diagnosis of cirrhosis.

  1992cited by this paper
• A simple biological index for detection of alcoholic liver disease in drinkers.

  1991cited by this paper
• Snake skin pattern gastropathy in cirrhotic patients

  1991cited by this paper
• Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies

  1991cited by this paper
• Clinical indicants of compensated cirrhosis: A prospective study

  1990cited by this paper
• Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction.

  1990cited by this paper
• Endoscopic and histologic appearance of the gastric mucosa in patients with portal hypertension.

  1990cited by this paper
• Diagnosis of liver cirrhosis with US: receiver-operating characteristic analysis of multidimensional caudate lobe indexes.

  1989cited by this paper
• Cirrhosis: diagnosis with sonographic study of the liver surface.

  1989cited by this paper
• Evaluation of the incidence and significance of the "mosaic pattern" in patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction.

  1988cited by this paper
• Frequency of upper gastrointestinal lesions in patients with liver cirrhosis

  1988cited by this paper
• Serum hyaluronate in primary biliary cirrhosis—A biochemical marker for progressive liver damage

  1988cited by this paper
• [Natural history of esophageal varices in cirrhosis (from origin to rupture)].

  1988cited by this paper
• Interobserver agreement in the physical diagnosis of alcoholic liver disease

  1987cited by this paper
• Portal hypertensive gastric mucosa: an endoscopic study.

  1986cited by this paper
• Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.

  1986cited by this paper
• Cirrhosis: value of caudate to right lobe ratio in diagnosis with US.

  1986cited by this paper
• Serum hyaluronate in liver diseases: Study by enzymoimmunological assay

  1986cited by this paper
• Increased serum levels of hyaluronate in liver disease

  1985cited by this paper
• Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

  1985cited by this paper
• Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques--a review.

  1982cited by this paper
• A 20-year prospective study of cirrhosis.

  1981cited by this paper

• Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment

  2026cites this paper
• Trends in Liver Cirrhosis and Diabetes-Related Mortality Among Adults in the United States: A CDC WONDER Database Analysis (1999–2020)

  2025cites this paper
• Spontaneous splenic rupture associated with Q fever and portal hypertension: A case report

  2025cites this paper
• Circulating Endotrophin as a Biomarker of Fibrosis in Chronic Liver Diseases.

  2025cites this paper
• Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.

  2024cites this paper
• Noninvasive Tests in Assessment of Patients with Alcohol-Associated Liver Disease.

  2024cites this paper
• Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis

  2024cites this paper
• Serologic biomarkers and scoring systems for hepatic fibrosis in obese children with nonalcoholic steatohepatitis

  2023cites this paper
• Abdominal ultrasound findings in adult patients with cystic fibrosis.

  2022cites this paper
• Application of ultrasound for the diagnosis of cirrhosis/portal hypertension

  2022cites this paper
• Impact of non-invasive biomarkers on hepatology practice: Past, present and future.

  2022cites this paper
• Staging Fibrosis in Chronic Viral Hepatitis

  2022cites this paper
• Hallazgos de la ecografía abdominal en pacientes adultos con fibrosis quística

  2022cites this paper
• Evaluation of Portal Venous Flow as a Non-invasive Method for Diagnosing Liver Fibrosis in Patients with Chronic Hepatitis B

  2021cites this paper
• Approach to the Patient with Liver Disease

  2021cites this paper
• An ultrasound image‐based deep multi‐scale texture network for liver fibrosis grading in patients with chronic HBV infection

  2021cites this paper
• Similar 5‐year HCC occurrence in Tenofovir‐ and Entecavir‐treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort

  2021cites this paper
• Evaluation of ethnic influence in the application of a hepatocellular carcinoma predictive model for chronic hepatitis C

  2021cites this paper
• Traitement de l’infection par le virus de l’hépatite C (VHC)

  2020cites this paper
• Microbial Etiology of Pyogenic Vertebral Osteomyelitis According to Patient Characteristics

  2020cites this paper
• Impacto de la afectación hepatobiliopancreática y el estatus nutricional en la sobrevida de adultos con fibrosis quística

  2020cites this paper
• Noninvasive Biomarkers for Liver Fibrosis

  2020cites this paper
• Grading Bleomycin‐Induced Pulmonary Fibrosis in ex vivo Mouse Lungs Using Ultrasound Image Analysis

  2020cites this paper
• Treatment of hepatitis C virus infection.

  2020cites this paper
• Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.

  2019cites this paper
• STUDY TO ANALYZE THE USE OF NON-INVASIVE PARAMETERS TO DETERMINE VARIOUS STAGES OF LIVER FIBROSIS IN CHRONIC HEPATITIS C VIRUS (HCV) PATIENTS

  2019cites this paper
• Non-Invasive Markers of Liver Fibrosis

  2019cites this paper
• A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B

  2019cites this paper
• CHARACTERIZATION OF PORTAL HYPERTENSION IN GEZIRASTATE (SUDAN) USING ULTRASOUND

  2019cites this paper
• Characterization of brain microstructural abnormalities in cirrhotic patients without overt hepatic encephalopathy using diffusion kurtosis imaging

  2019cites this paper
• Advances in ultrasound diagnosis in chronic liver diseases

  2019cites this paper
• Prevalence of cryptococcal antigenemia in hospitalized patients with liver cirrhosis.

  2019cites this paper
• Use of serum biomarkers in staging of canine hepatic fibrosis

  2019cites this paper
• CLINICAL AND LABORATORIAL CHARACTERISTICS OF THE LIVER IN AGED AND NON-AGED ALCOHOLICS

  2019cites this paper
• The remarkable history of the hepatitis C virus

  2019cites this paper
• Type III collagen

  2019cites this paper
• Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis

  2018cites this paper
• A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis

  2018cites this paper
• Extracellular Matrix Remodeling with Focus on Biochemical Markers in Liver Fibrosis: Limitations and Possibilities

  2018cites this paper
• The Spleen Promotes the Secretion of CCL2 and Supports an M1 Dominant Phenotype in Hepatic Macrophages During Liver Fibrosis

  2018cites this paper
• Non-Invasive Markers for Liver Fibrosis in Chronic HCV Patients

  2018cites this paper
• Pathological findings that contribute to tissue stiffness in the spleen of liver cirrhosis patients

  2018cites this paper
• Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy

  2018cites this paper
• Alcoholic liver disease

  2018cites this paper
• Proof of principle: Estimation of liver function using color coded Doppler sonography of the portal vein

  2018cites this paper
• Ultrasound diagnosis of hepaticfibrosis and steatosis

  2018cites this paper
• Hyaluronic acid and TGF-β1 in dogs with hepatobiliary diseases

  2018cites this paper
• Low expression of NKD2 is associated with enhanced cell proliferation and poor prognosis in human hepatocellular carcinoma.

  2018cites this paper
• Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis

  2018cites this paper
• Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion

  2017cites this paper
• Ultrasonography for Noninvasive Assessment of Portal Hypertension

  2017cites this paper
• The spleen in liver cirrhosis: revisiting an old enemy with novel targets

  2017cites this paper
• Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein levels and liver fibrosis: A meta‐analysis

  2017cites this paper
• The noninvasive diagnosis of esophageal varices and its application in clinical practice.

  2017cites this paper
• Non-invasive tests and markers for liver fibrosis

  2017cites this paper
• Noninvasive Diagnostic and Prognostic Assessment Tools for Liver Fibrosis and Cirrhosis in Patients with Chronic Liver Disease

  2017cites this paper
• Genetic Study for the Role and Predictive Consequence of Certain Cytokines in Hepatitis B Iraqi Patients

  2017cites this paper
• Serum WFA +-M 2 BP levels predict liver fibrosis , development of hepatocellular carcinoma , and overall survival : A meta-analysis

  2017cites this paper
• Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis

  2016cites this paper
• Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application.

  2016cites this paper
• Correlation between Serum Hyaluronic Acid with Steatosis, Non alcoholic Steato-hepatitis and Fibrosis in Patients with Chronic Hepatitis C Virus Infection.

  2016cites this paper
• Portal response related to shunt occlusion by balloon‐occluded retrograde transvenous obliteration may determine the prognosis of cirrhosis

  2016cites this paper
• Serum concentrations of PIIINP aminopeptide in dogs with liver fibrosis.

  2016cites this paper
• Four-dimensional flow magnetic resonance imaging in cirrhosis.

  2016cites this paper
• Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion

  2016cites this paper
• Serum hyaluronic acid as non invasive biomarker to predict liver fibrosis in viral hepatitis patients

  2016cites this paper
• Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis

  2016cites this paper
• Etiological profile of cirrhosis of liver from North-East India with reference to their anti-hepatitis A virus seroprevalence

  2015cites this paper
• An albumin, collagen IV, and longitudinal diameter of spleen scoring system superior to APRI for assessing liver fibrosis in chronic hepatitis B patients.

  2015cites this paper
• Efficacy of gadoxetic acid‐enhanced magnetic resonance cholangiography compared with T2‐weighted magnetic resonance cholangiography in patients with liver cirrhosis

  2015cites this paper
• Biomarkers of Extracellular Matrix Remodeling in Liver Diseases

  2015cites this paper
• Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac‐2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis

  2015cites this paper
• New methods to detect liver fibrosis severity and predict clinical outcomes in chronic hepatitis C infection

  2015cites this paper
• Assessment of the external validity of a predictive score for blood transfusion in liver surgery.

  2015cites this paper
• Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses

  2015cites this paper
• Fibrose hépatique : physiopathologie, diagnostic, pronostic

  2015cites this paper
• Diagnostic imaging modalities

  2015cites this paper
• Acide hyaluronique

  2015cites this paper
• Cirrhosis Diagnosis and Liver Fibrosis Staging: Transient Elastometry Versus Cirrhosis Blood Test

  2014cites this paper
• Magnetic Resonance Imaging in Cirrhosis: What’s New?

  2014cites this paper
• Chronic hepatitis C and liver fibrosis.

  2014cites this paper
• Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

  2014cites this paper
• Scores d’évaluation biologique de la fibrose hépatique

  2014cites this paper
• Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease

  2014cites this paper
• Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value

  2014cites this paper
• Non-invasive diagnosis of alcoholic liver disease.

  2014cites this paper
• Clinical Application of Non-Invasive Markers of Liver Fibrosis

  2013cites this paper
• Nicht-invasive Evaluation der hepatischen Manifestation bei Patienten mit Morbus Wilson mittels Transienter Elastographie, Acoustic Radiation Force Impulse (ARFI)-Elastographie und verschiedener laborbasierter Fibrose-Indices

  2013cites this paper
• Alcool et marqueurs biologiques

  2013cites this paper
• Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers

  2013cites this paper
• The application of molecular profiling and proteomics in the study of liver cancers

  2013cites this paper
• The thalamus in cirrhotic patients with and without hepatic encephalopathy: a volumetric MRI study.

  2013cites this paper
• Markers in nonalcoholic steatohepatitis.

  2013cites this paper
• Tissue Doppler imaging and tissue strain imaging for the evaluation of hepatic fibrosis in patients with chronic hepatitis B.

  2013cites this paper
• Liver fibrosis assessment using transient elastography guided with real-time B-mode ultrasound imaging: a feasibility study.

  2013influential citation
• Non-invasive assessment of liver fibrosis

  2012cites this paper
• An In Vitro and In Vivo Analysis of the Correlation between Susceptibility-Weighted Imaging Phase Values and R2* in Cirrhotic Livers

  2012cites this paper
• Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults

  2012cites this paper
• Does this patient with liver disease have cirrhosis?

  2012cites this paper
• How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?

  2012cites this paper